5L4J

Crystal Structure of Human Transthyretin in Complex with 4,4'-Dihydroxydiphenyl sulfone (Bisphenol S, BPS)

Summary for 5L4J

• Entry DOI: 10.2210/pdb5l4j/pdb
• Related: 1F41
• Descriptor: Transthyretin, 4-(4-hydroxyphenyl)sulfonylphenol, SODIUM ION, ... (4 entities in total)
• Functional Keywords: transport protein, thyroxine binding, 4, 4'-dihydroxydiphenyl sulfone (bisphenol s, bps) complex
• Biological source: Homo sapiens (Human)
• Cellular location: Secreted: P02766
• Total number of polymer chains: 2
• Total formula weight: 28078.25

Authors

Grundstrom, C.,Hall, M.,Zhang, J.,Olofsson, A.,Andersson, P.,Sauer-Eriksson, A.E. (deposition date: 2016-05-25, release date: 2016-10-12, Last modification date: 2024-01-10)

Primary citation

Zhang, J.,Begum, A.,Brannstrom, K.,Grundstrom, C.,Iakovleva, I.,Olofsson, A.,Sauer-Eriksson, A.E.,Andersson, P.L.
Structure-Based Virtual Screening Protocol for in Silico Identification of Potential Thyroid Disrupting Chemicals Targeting Transthyretin.
Environ. Sci. Technol., 50:11984-11993, 2016

PubMed Abstract: Thyroid disruption by xenobiotics is associated with a broad spectrum of severe adverse outcomes. One possible molecular target of thyroid hormone disrupting chemicals (THDCs) is transthyretin (TTR), a thyroid hormone transporter in vertebrates. To better understand the interactions between TTR and THDCs, we determined the crystallographic structures of human TTR in complex with perfluorooctanesulfonic acid (PFOS), perfluorooctanoic acid (PFOA), and 2,2',4,4'-tetrahydroxybenzophenone (BP2). The molecular interactions between the ligands and TTR were further characterized using molecular dynamics simulations. A structure-based virtual screening (VS) protocol was developed with the intention of providing an efficient tool for the discovery of novel TTR-binders from the Tox21 inventory. Among the 192 predicted binders, 12 representatives were selected, and their TTR binding affinities were studied with isothermal titration calorimetry, of which seven compounds had binding affinities between 0.26 and 100 μM. To elucidate structural details in their binding to TTR, crystal structures were determined of TTR in complex with four of the identified compounds including 2,6-dinitro-p-cresol, bisphenol S, clonixin, and triclopyr. The compounds were found to bind in the TTR hormone binding sites as predicted. Our results show that the developed VS protocol is able to successfully identify potential THDCs, and we suggest that it can be used to propose THDCs for future toxicological evaluations.

PubMed: 27668830
DOI: 10.1021/acs.est.6b02771

Experimental method

X-RAY DIFFRACTION (1.62 Å)